Scarica l'app Stockscreener
6.76
5.30%
0.34
Dopo l'orario di chiusura:
5.51
-1.25
-18.49%
Precedente Chiudi:
$6.42
Aprire:
$6.23
Volume 24 ore:
1.10M
Relative Volume:
1.67
Capitalizzazione di mercato:
$464.74M
Reddito:
-
Utile/perdita netta:
$-93.56M
Rapporto P/E:
-2.3836
EPS:
-2.8361
Flusso di cassa netto:
$-85.76M
1 W Prestazione:
+5.62%
1M Prestazione:
+37.68%
6M Prestazione:
+428.12%
1 anno Prestazione:
+196.49%
Intervallo 1D:
$5.97
$6.78
Intervallo di 1 settimana:
$5.87
$6.78
Portata 52W:
$0.8801
$7.80
Pepgen Inc Stock (PEPG) Company Profile
Nome
Pepgen Inc
Settore
Industria
Telefono
703-456-8000
Indirizzo
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Compare PEPG vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
6.76 | 441.36M | 0 | -93.56M | -85.76M | -2.8361 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-09 | Iniziato | Guggenheim | Buy |
| 2024-12-16 | Downgrade | BofA Securities | Neutral → Underperform |
| 2024-07-31 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-12-21 | Iniziato | H.C. Wainwright | Buy |
Pepgen Inc Borsa (PEPG) Ultime notizie
PepGen's Phase 2 Trial of Drug to Treat Multisystem Disorder Placed on Hold by US FDA - marketscreener.com
US FDA puts partial clinical hold on PepGen's muscle disease drug trial - Reuters
FDA places partial clinical hold on PepGen’s DM1 trial - Investing.com India
Biotech firm PepGen's Q4 net loss narrows - TradingView
PepGen Faces FDA Partial Hold Amid Ongoing FREEDOM2 Trial - TipRanks
PepGen stock plunges 26% on FDA partial clinical hold - Investing.com
PepGen IncU.S. FDA places Freedom2 trial on partial clinical hold related to preclinical pharmacology and toxicology - marketscreener.com
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights - Yahoo Finance
PepGen Announces Regulatory Updates on FREEDOM2 - Business Wire
PEPG Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
PepGen to Participate in the Leerink Global Healthcare Conference - PharmiWeb.com
PepGen to join fireside chat at LeerinkPartners Global Healthcare Conference in Miami - Traders Union
Dividend Watch: Is ArrowMark Financial Corp currently under institutional pressure2025 Breakouts & Breakdowns & Proven Capital Preservation Tips - baoquankhu1.vn
Monashee Investment Management LLC Invests $1.39 Million in PepGen, Inc. $PEPG - MarketBeat
Oppenheimer Initiates Coverage of PepGen (PEPG) with Outperform Recommendation - Nasdaq
PepGen (NASDAQ:PEPG) Now Covered by Analysts at Oppenheimer - MarketBeat
Oppenheimer Initiates PepGen at Outperform With $15 Price Target - marketscreener.com
PepGen, Inc. (NASDAQ:PEPG) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Will PepGen Inc. stock go up in YEARWeekly Investment Summary & Smart Swing Trading Alerts - mfd.ru
Should I set a stop loss on PepGen Inc.Market Trend Review & Fast Gaining Stock Strategy Reports - mfd.ru
PepGen Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView
Guggenheim raises PepGen stock price target to $7 on trial outlook - Investing.com Nigeria
Guggenheim raises PepGen stock price target to $7 on trial outlook By Investing.com - Investing.com South Africa
PepGen (PEPG) Expected to Announce Earnings on Monday - MarketBeat
Does PepGen Inc. have a sustainable dividendForecast Cut & Precise Swing Trade Entry Alerts - mfd.ru
PEPG SEC FilingsPepGen Inc 10-K, 10-Q, 8-K Forms - Stock Titan
PepGen’s FREEDOM-DM1 Trial Reaches Early Safety Milestone for Myotonic Dystrophy - TipRanks
What technical signals suggest for PepGen Inc. stockProfit Target & Verified Entry Point Signals - mfd.ru
Can PepGen Inc. stock sustain institutional interestJuly 2025 Trends & Verified Swing Trading Watchlists - mfd.ru
Will PepGen Inc. benefit from rising consumer demandEarnings Beat & Detailed Earnings Play Alerts - mfd.ru
Why PepGen Inc. stock is in analyst buy zoneChart Signals & Precise Swing Trade Entry Alerts - mfd.ru
Can PepGen Inc. stock double in the next yearJuly 2025 Pullbacks & Capital Efficiency Focused Ideas - mfd.ru
Risk On: Should I set a stop loss on PepGen IncJuly 2025 Setups & Weekly High Potential Alerts - baoquankhu1.vn
How much upside is left in PepGen (PEPG)? Wall Street analysts think 75.44% - MSN
Whale Trades: What are PepGen Incs growth leversJuly 2025 Volume & AI Driven Price Predictions - baoquankhu1.vn
PepGen, Inc. (NASDAQ:PEPG) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
PepGen reports Q3 EPS (52c), consensus (56c) - MSN
Levi & Korsinsky Notifies PepGen Inc. (PEPG) InvestorsLead Plaintiff Deadline on August 8, 2025 - The National Law Review
PepGen (NASDAQ:PEPG) Trading Down 2.6%What's Next? - MarketBeat
PepGen (NASDAQ:PEPG) Trading Down 2.6% – What’s Next? - Defense World
Risk Check: Will PepGen Inc benefit from rising consumer demandJuly 2025 Update & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Aug Retail: Does PepGen Inc have declining or rising EPSTrade Risk Summary & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Gains Report: Is electroCore Incs ROIC above industry averageWeekly Gains Summary & Real-Time Volume Surge Alerts - baoquankhu1.vn
Levels Update: Is Fox Corporation stock a buy or sellJuly 2025 Macro Moves & Long-Term Growth Plans - baoquankhu1.vn
PepGen outlines clinical trial phases for clarity - Traders Union
Risks Report: How liquid is PepGen Inc. stockWeekly Stock Recap & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Is PepGen Inc. a good stock for dollar cost averagingJuly 2025 Price Swings & Daily Price Action Insights - bollywoodhelpline.com
Does PepGen Inc have a sustainable dividendMarket Performance Report & Target Return Focused Stock Picks - baoquankhu1.vn
Earnings Miss: How rising interest rates impact XAI Octagon Floating Rate Alternative Income Trust stock2025 Support & Resistance & Momentum Based Trading Ideas - moha.gov.vn
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - MSN
Can PepGen Inc. stock deliver consistent earnings growth2025 Short Interest & Precise Swing Trade Entry Alerts - Улправда
Pepgen Inc Azioni (PEPG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.11%
6.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):